Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|July 21, 2015
iNKT and MAIT Cell Alterations in DiabetesIsabelle Magalhaes, Badr Kiaf, Agnès LehuenBiorxiv : the Preprint Server for Biology|March 30, 2023
Gata3 is detrimental to regulatory T cell function in autoimmune diabetesBadr Kiaf, Kevin Bode, Cornelia Schuster, et al.Genes and Immunity|August 23, 2019
The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse modelJanice M Nieves-Bonilla, Badr Kiaf, Cornelia Schuster, et al.Frontiers in Immunology|June 20, 2022
CD5 Controls Gut Immunity by Shaping the Cytokine Profile of Intestinal T CellsCornelia Schuster, Badr Kiaf, Teri Hatzihristidis, et al.Nature Metabolism|July 29, 2020
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetesErica P Cai, Yuki Ishikawa, Wei Zhang, et al.Nature Communications|July 26, 2020
Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesityAmine Toubal, Badr Kiaf, Lucie Beaudoin, et al.Nature Immunology|June 9, 2018
Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer DaSilva, Lucie Beaudoin, et al.Nature Immunology|October 10, 2017
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer Da Silva, Lucie Beaudoin, et al.Nature Communications|June 3, 2018
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liverPushpa Hegde, Emmanuel Weiss, Valérie Paradis, et al.The Journal of Clinical Investigation|March 10, 2015
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patientsIsabelle Magalhaes, Karine Pingris, Christine Poitou, et al.Pageof 1